Amber DeJohn
NIH Grant: National, Multidimensional Measures of Healthcare Accessibility for AD/ADRD Risk Factors
Amber DeJohn will lead a new NIH-funded GECC project to measure and map healthcare accessibility for Alzheimer's-related risk factors.

Center Faculty Dr. Amber DeJohn (Principal Investigator) has been recently awarded the project “National, Multidimensional Measures of Healthcare Accessibility for AD/ADRD Risk Factors,” funded by the NIH-supported Gateway Exposome Coordinating Center (GECC). More to come.